This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renehan, A. G. Articles by Shalet, S. M. Search for Related Content PubMed PubMed Citation Articles by Renehan, A. G. Articles by Shalet, S. M.

The Prevalence and Characteristics of Colorectal Neoplasia in Acromegaly

Departments of Surgery (A.G.R., J.E.P., S.T.O.) and Endocrinology (S.M.S.), Christie Hospital National Health Service Trust, and Department of Pathology, South Manchester University Hospitals (N.H.), Manchester, United Kingdom M20 4BX; and Departments of Surgery (P.B., J.V.) and Endocrinology (S.G.B.), University of Newcastle, Newcastle, United Kingdom NE2 4HH

Address all correspondence and requests for reprints to: Prof. S. M. Shalet, Department of Surgery, Christie Hospital National Health Service Trust, Wilmslow Road, Manchester, United Kingdom M20 4BX. E-mail: arenehan{at}picr.man.ac.uk

An increased prevalence of colorectal neoplasia has been reported in acromegalic patients, and recommendations have been made for early colonoscopic screening and regular surveillance. This assumption, however, is frequently drawn from studies using selected control populations. To clarify colonoscopic management in these patients, we undertook a 2-center prospective screening colonoscopy study in 122 acromegalics (age range, 25–82 yr). In the absence of ideal age-matched controls, we calculated prevalence rates of occult adenocarcinomas and adenomas in the general population using cumulative data in the published literature from 8 autopsy studies (model 1, n = 3559) and 4 screening colonoscopy studies (model 2, n = 810), applying linear regression models. Of the 115 patients with complete examinations, adenocarcinomas were discovered in 3 (2.6%), and at least 1 adenoma was found in 11, giving an overall prevalence of neoplasia of 12% (14 of 115). Prevalence rates for age bands 30–40, 40–49, 50–59, 60–69, and 70+ yr were 0%, 8%, 12%, 20%, and 21%, respectively. Compared with the 2 control models, the prevalence of occult colorectal cancer was not significantly increased (acromegalics vs. models 1 and 2, 2.6% vs. 2.3% and 0.9%), nor was there an increase in the prevalence of adenomas in any age band. Pathological characteristics showed some differences, in that adenomas in acromegalics tended to be right sided (68% vs. 57% and 56%), larger (for 10 mm, 27% vs. 13% and 9%), and of advanced histology (for tubulovillous, 27% vs. 4% and 22%). No associations were found between the presence of colonic neoplasia and the duration of disease, total GH exposure, cure status, and serum insulin-like growth factor I. This study has failed to demonstrate an increased prevalence of neoplasia in acromegalic patients compared with the expected prevalence in the general population and questions the need for an aggressive colonoscopic screening policy.

This article has been cited by other articles:

				E. Resmini, A. Tagliafico, L. Bacigalupo, G. Giordano, E. Melani, A. Rebora, F. Minuto, G. A. Rollandi, and D. Ferone Computed Tomography Colonography in Acromegaly J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 218 - 222. [Abstract] [Full Text] [PDF]

				F. Bogazzi, C. Cosci, C. Sardella, A. Costa, L. Manetti, M. Gasperi, G. Rossi, L. Bartalena, and E. Martino Identification of Acromegalic Patients at Risk of Developing Colonic Adenomas J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1351 - 1356. [Abstract] [Full Text] [PDF]

				M. Terzolo, G. Reimondo, M. Gasperi, R. Cozzi, R. Pivonello, G. Vitale, A. Scillitani, R. Attanasio, E. Cecconi, F. Daffara, et al. Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 84 - 90. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				C. Parkinson, W. M. Drake, M. E. Roberts, K. Meeran, G. M. Besser, and P. J. Trainer A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1797 - 1804. [Abstract] [Full Text] [PDF]

				S. Melmed CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2929 - 2934. [Full Text] [PDF]

				P. J. Jenkins and M. Besser CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2935 - 2941. [Full Text] [PDF]